Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022)
Ovid Therapeutics (OVID) posted Tax Provisions of $50000.0 for Q1 2022, up 114.3% on a QoQ basis from -$349714.0 in Q4 2021, and down 90.01% year-over-year from $500277.0 in Q1 2021.
Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022) Analysis & Trends
Ovid Therapeutics' Tax Provisions history runs 2 years deep, the most recent figure standing at $50000.0 for Q1 2022.
- Quarterly Tax Provisions fell 90.01% year-over-year to $50000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $50000.0 (down 96.24% YoY) and the FY2021 annual result came in at $1.3 million, changed N/A from the prior year.
- Tax Provisions was $50000.0 for Q1 2022 at Ovid Therapeutics, up from -$349714.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.5 million in Q2 2021 and bottomed at -$349714.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Ovid Therapeutics | 120.66 Mn | -34.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | -349,714.00 |
| Sep 30, 2021 | -294,829.00 |
| Jun 30, 2021 | 1.47 Mn |
| Mar 31, 2021 | 500,277.00 |